Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital
Banqiao District, New Taipei, 22050, Taiwan
Not Yet Recruiting
NCT Number: NCT06535334
Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer
This study aims to compare intravenous chemotherapy versus intraperitoneal chemotherapy in patients with recurrent ovarian cancer.
Not Yet Recruiting
Trial opening soon.
Get NotifiedKey information
Age range
20 year and older
Sex eligibility
Female
Study type
Observational
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- women who had recurrent ovarian cancer and was treated with either intravenous or intraperitoneal platinum based chemotherapy
Exclusion criteria
- women who did not complete the designated treatment course (exception to those who had to quit due to progressive disease or death of any cause)
Treatment and study plan
Chemotherapy
DrugIntravenous chemotherapy versus intraperitoneal chemotherapy in recurrent ovarian cancer
Primary outcomes
-
RFS
Time frame: the time interval from the date of surgery or the start of chemotherapy to clinically defined recurrence, disease progression, death from any cause or last follow-up
Recurrence free survival
-
OS
Time frame: the time interval from the date of surgery or the start of chemotherapy to the date of death from any cause or last follow-up
Overall Survival
Sponsors and collaborators
Lead sponsor
Far Eastern Memorial Hospital
Other
Registry information
Official study title
Intravenous Chemotherapy Versus Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer
Important dates
- Study start
- 2024
- Primary completion
- 2025
- Study completion
- 2026
- First posted
- Aug 2, 2024
- Registry last updated
- Aug 2, 2024
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.